[PDF] Top 20 Curricular training report in a CRO and pharmaceutical industry

... my training I had the opportunity to develop the different activities inherent to the phases of a clinical trial life cycle (Feasibility, Initiation, Monitoring and ...activities in the study ... See full document

... authorities. In Portugal, this entity is CEIC (Comissão de Ética para a Investigação ...conception and pertinence, a convenient risk-benefit, among other ...common in all the member- estates, ... See full document

... Discovering and developing new drugs is a complex and long-term process that consists of several stages and involves various players ...The pharmaceutical R&D (Figure 3) begins with drug ... See full document

... visits and COVs and writing some of the correspondent reports, another objective was successfully completed, as techniques were learned and skills inherent to the clinical studies’ monitoring were ... See full document

... locked and ready for statistical analysis, and the study conduct has ...organized and will remain intact and be accessible in the future as needed for regulatory ...later and ... See full document

... submission and implementation at a USF, because this facility does not have the same characteristics as a ...a pharmaceutical service at the USF, which is a requirement to CT´s conduction, according to Law ... See full document

... learned and experienced during my internship I have to assume that it was more than I have ever ...hard and soft skills, which will be very valuable during my ...my training. The ... See full document

... the pharmaceutical analysis and/or to obtain any additional information needed for the scientific evaluation of the ...case. In fact, in the great majority of the reports that I processed, I ... See full document

... advice and protocol assistance, community marketing authorization and national incentives ...Food and Drug Administration (FDA) created a draft guidance for adaptive design for clinical ...not ... See full document

... them. In addition this chapter is also a reflection about the work experience acquired during the 10 months of the on the job ...the pharmaceutical world - working ...the pharmaceutical world ... See full document

... knowledge and training in this domain. I believe that the training on the management system and its implementation that has been given over time was critical to systematize the ... See full document

... opportunities and in establishing strategies to achieve them, in order to increase market ...forefront in relation to competitors. Bluepharma´s BD department was created in 2009 as a ... See full document

... service CRO founded in 2007. After two years in Cantanhede, in Biocant Park, it moved to centre of Coimbra, where it is currently ...a CRO, Novexem Portugal provides scientific ... See full document

... For pharmaceutical companies the perception of a suitable environment for investment, is a key factor in the selection of the country that will receive the ...CT. In this decision are evaluated ... See full document

... processes in which chemical 1 or microbiological conversion 2 of material takes place in conjunction with the transfer of mass, heat, and momentum 3-5 ...plants) and on a large scale ... See full document

... health and leading a healthy life, showing interest in food that contain bioactive or functional ingredients (especially natural ones) that increase food nutritional value and health status [13] ... See full document

... drugs in that same category. Market size increases profits, and technolog- ical change is then directed toward these more profitable ...Jones and Romer (2006) show that insurance plans reinforce the ... See full document

... professionals and manage several activities that were my responsibility. In order to ensure that nothing would be forgotten, I had to improve my organizational ...purpose in order to record all the ... See full document

... performance in the pharmaceutical ...fast and profound that it is quite difficult for the companies to follow them ...pharmaceutical industry. How- ever, changes do indeed represent new ... See full document

... aspirin in patients with acute coronary syndrome and in patients which suffered heart attacks versus a group of patients using aspirin and a ...event in patients who had suffered from ... See full document